image by: HWN

HWN Suggests

Akkermansia: The New “It” Probiotic — Hype or Real Help?

The gut microbiome is a complex ecosystem—billions of bacteria, fungi, and other microbes interacting with your diet, immune system, and environment. Trying to fix chronic digestive issues by adding one species is like trying to restore a rainforest by planting a single type of tree. Real improvements come from identifying and addressing root causes: diet triggers, infections, overgrowths, inflammation, and other imbalances. The Bottom Line on Akkermansia... It’s new and interesting, but human research is still early. Levels can be tested through advanced stool analysis. Hype exceeds evidence, especially in marketing claims. Verdict: I’ve never seen it help a patient and the results are…

read full article

Featured

 Akkermansia muciniphila: is it the Holy Grail for ameliorating metabolic diseases?

The increasing prevalence of metabolic diseases has become a severe public health problem. Gut microbiota play important roles in maintaining human health by modulating the host’s metabolism. Recent evidences demonstrate that Akkermansia muciniphila is effective in improving metabolic disorders and is thus considered as a promising “next-generation beneficial microbe”.

 Getting To Know Your Gut Bugs: Akkermansia Muciniphila

Named after its preferred energy source, Akkermansia muciniphila feeds on mucin, a glycoprotein that regulates the thickness of our gut’s intestinal mucosal layer (6). As a byproduct of munching on mucin, Akkermansia produces propionate and acetate, two short-chain fatty acids (SCFAs) that feed other beneficial gut bacteria to make butyrate, a SCFA and vital energy source for mucus-secreting goblet cells and intestinal epithelial cells. Scientists call this cross-feeding. SCFAs strengthen tight junctions (the glue that holds our intestinal cells together) and prevent unwanted materials from passing through and into circulation. Think of your gut lining as a coffee filter, it lets the good stuff (coffee) in and keeps the bad stuff (coffee grinds) out. Here, the “bad stuff” represents allergens, endotoxins, fecal matter, and food particles, and the “good stuff” represents macro and micronutrients from real whole foods.

Articles of Interest

A Critical Perspective on the Supplementation of Akkermansia muciniphila: Benefits and Harms

Akkermansia muciniphila is a mucin-degrading bacterium of the intestinal niche, exerting beneficial effects on the host metabolic profile. Accumulating evidence indicated Akkermansia as a promising therapeutic probiotic against metabolic disorders such as obesity, type 2 diabetes and cardiovascular diseases. However, in specific intestinal microenvironments, its excessive enrichment may be not beneficial.

A Probiotic for Obesity?

People with metabolic disorders may benefit from supplements of a common gut bacterium, a small pilot study suggests.

Akkermansia muciniphila and Gut Immune System: A Good Friendship That Attenuates Inflammatory Bowel Disease, Obesity, and Diabetes

Gut dysbiosis has been proposed to be a risk factor for the development of inflammatory and metabolic diseases. Restoring a balanced microbiota and modulating the gut–immune system axis using probiotics has been increasingly studied as a therapeutic strategy for these diseases. It has already been verified that A. muciniphila is capable of attenuating metabolic syndrome and damage to the intestinal mucosa by inducing an anti-inflammatory response and controlling intestinal homeostasis.

Akkermansia muciniphila is a promising probiotic

Akkermansia muciniphila (A. muciniphila), an intestinal symbiont colonizing in the mucosal layer, is considered to be a promising candidate as probiotics. A. muciniphila is known to have an important value in improving the host metabolic functions and immune responses. Moreover, A. muciniphila may have a value in modifying cancer treatment. However, most of the current researches focus on the correlation between A. muciniphila and diseases, and little is known about the causal relationship between them. Few intervention studies on A. muciniphila are limited to animal experiments, and limited studies have explored its safety and efficacy in humans.

Akkermansia muciniphila: A promising probiotic against inflammation and metabolic disorders

Metabolic disease is a worldwide epidemic that has become a public health problem. Gut microbiota is considered to be one of the important factors that maintain human health by regulating host metabolism. As an abundant bacterium in the host gut, A. muciniphila regulates metabolic and immune functions, and protects gut health. Multiple studies have indicated that alterations in the abundance of A. muciniphila are associated with various diseases, including intestinal inflammatory diseases, obesity, type 2 diabetes mellitus, and even parasitic diseases.

Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms

Ever since Akkermansia muciniphila was discovered and characterized two decades ago, numerous studies have shown that the lack or decreased abundance of this commensal bacterium was linked with multiple diseases (such as obesity, diabetes, liver steatosis, inflammation and response to cancer immunotherapies). Although primarily based on simple associations, there are nowadays an increasing number of studies moving from correlations to causality. The causal evidence derived from a variety of animal models performed in different laboratories and recently was also recapitulated in a human proof-of-concept trial.

Akkermansia Probiotic: 4 Popular Claims, Fact-Checked

If you’ve read or watched something about a new probiotic called Akkermansia recently, you might think you’d stumbled on the holy grail of gut health. The number of claims surrounding Akkermansia (and circulating on social media) is staggering. It’s easy to see why it has garnered so much attention. People laud its potential to improve metabolic health, regulate weight, and even boost the immune system. However, while early studies have been promising, the surge in hype around this microbe may not be entirely warranted.

Potential Effects of Akkermansia Muciniphila in Aging and Aging-Related Diseases: Current Evidence and Perspectives

Akkermansia muciniphila (A. muciniphila) is an anaerobic bacterium that widely colonizes the mucus layer of the human and animal gut. The role of this symbiotic bacterium in host metabolism, inflammation, and cancer immunotherapy has been extensively investigated over the past 20 years. Recently, a growing number of studies have revealed a link between A. muciniphila, and aging and aging-related diseases (ARDs).

This mucus‑loving gut bacteria is important for health – here’s how to keep it happy

Akkermansia muciniphila is a very fussy eater. It only uses the glycoproteins (molecules containing protein and carbohydrates) in mucin as an energy source. But just how this bacteria extracted energy from glycoproteins was a mystery until recently. Research conducted by myself and colleagues discovered that A muciniphila deploys a range of different enzymes that work together in order to unlock the sugar found in mucin.

What Is Akkermansia? Here's Everything to Know Before You Start Taking Supplements

Akkermansia muciniphila is a beneficial strain of probiotic bacteria that lives in the mucus that covers epithelial cells in the lining of your gut. Akkermansia feeds on mucin (a protein in the mucus) and produces short chain fatty acids that “strengthen the tight junctions in between our gut cells, keeping the bad stuff out of our gut,” says Madiha Saeed, M.D., an integrative family physician and the author of several books including The Holistic Rx. “The more mucin Akkermansia uses, the more it encourages the epithelial cells to make more mucin, which then improves gut function and overall health.” It’s the only bacteria strain that does this in our gut, she adds.